A detailed history of Vident Advisory, LLC transactions in Smith & Nephew PLC stock. As of the latest transaction made, Vident Advisory, LLC holds 25,619 shares of SNN stock, worth $837,485. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25,619
Previous 19,855 29.03%
Holding current value
$837,485
Previous $608 Million 52.87%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$29.33 - $38.7 $169,058 - $223,066
5,764 Added 29.03%
25,619 $930 Million
Q2 2025

Aug 14, 2025

BUY
$24.97 - $30.63 $110,991 - $136,150
4,445 Added 28.84%
19,855 $608 Million
Q1 2025

May 15, 2025

SELL
$23.89 - $30.34 $147,019 - $186,712
-6,154 Reduced 28.54%
15,410 $437 Million
Q4 2024

Feb 14, 2025

BUY
$24.29 - $30.81 $321,405 - $407,677
13,232 Added 158.81%
21,564 $530 Million
Q3 2024

Nov 14, 2024

BUY
$24.51 - $31.64 $204,217 - $263,624
8,332 New
8,332 $259 Million

Others Institutions Holding SNN

About SMITH & NEPHEW PLC


  • Ticker SNN
  • Exchange OTC
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 435,348,000
  • Market Cap $14.2B
  • Description
  • Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabi...
More about SNN
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.